P09.4 Abnormal findings on neonatal screening for cystic fibrosis

Name of the Condition

• Abnormal findings on neonatal screening for cystic fibrosis

Summary

This condition refers to atypical results detected during routine newborn screening tests specifically for cystic fibrosis (CF), a genetic disorder affecting the lungs and digestive system. These screenings help identify infants with potential CF, enabling early intervention to manage symptoms and improve outcomes.

Causes

Abnormal findings may result from genetic mutations associated with cystic fibrosis, such as mutations in the CFTR gene. The screening detects elevated levels of immunoreactive trypsinogen (IRT) or other biomarkers indicative of CF, though further testing is needed to confirm the diagnosis.

Risk Factors

• Family history of cystic fibrosis.
• Ethnic background with higher prevalence of CF (e.g., Caucasian populations).
• Consanguinity or parental carrier status for CF mutations.

Symptoms

• Symptoms are often not immediately apparent at birth but may include poor weight gain, frequent respiratory infections, or greasy stools. Some infants may present with meconium ileus (intestinal blockage).

Diagnosis

Diagnosis is confirmed through follow-up testing after abnormal screening results, including sweat chloride testing, genetic analysis for CFTR mutations, or pancreatic function assessments. Newborn screening results alone are not diagnostic.

Treatment Options

• Airway clearance techniques (e.g., chest physical therapy).
• Enzyme replacement therapy for digestive issues.
• Inhaled medications to manage lung function.
• Nutritional support and supplements.

Prognosis and Follow-Up

Prognosis depends on early detection and adherence to treatment. Regular follow-up with a multidisciplinary team (pulmonologists, gastroenterologists) is essential to monitor growth, lung function, and nutritional status. Early intervention can improve quality of life and reduce complications.

Complications

• Chronic lung infections (e.g., pneumonia, bronchitis).
• Malnutrition or growth delays.
• Diabetes or liver disease in severe cases.

Lifestyle & Prevention

• Avoid exposure to smoke or respiratory irritants.
• Maintain a balanced diet with high-calorie, high-fat foods to support growth.
• Practice good hand hygiene to reduce infection risk.

When to Seek Professional Help

Seek immediate medical attention if the infant shows signs of respiratory distress, poor feeding, or failure to gain weight. Follow up promptly with a specialist if screening results are abnormal.

Tips for Medical Coders

Document the specific screening test used (e.g., IRT, DNA analysis) and any confirmatory results. Include details of follow-up testing or clinical evaluation to support the diagnosis. Ensure documentation aligns with clinical guidelines for cystic fibrosis screening and management.